Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Vaxxinity, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | S-1/A |
| Revenues | | 100.0% | 100.0% | |
| Cost of goods sold | | 56571.2% | 3276.8% | |
| Gross profit | | -56471.2% | -3176.8% | |
| Research and development | | 108150.0% | 3693.0% | |
| General and administrative | | 78522.7% | 2193.4% | |
| Depreciation | | 1669.7% | 128.7% | |
| EBIT | | -189507.6% | -5795.7% | |
| Pre-tax income | | -207840.9% | -7173.6% | |
| Income taxes | | 0.0% | 0.0% | |
| Net income | | -207840.9% | -7173.6% | |
|